Alvimopan, a Peripherally Acting μ-Opioid Receptor Antagonist, is Associated with Reduced Costs after Radical Cystectomy: Economic Analysis of a Phase 4 Randomized, Controlled Trial
Journal of Urology | December 14, 2013 | Volume: 191 | Issue: 6 | Pages: 1721-1727
10.1016/j.juro.2013.12.015
| PMID 24342144